CN105999219A - Medicine for expelling noxious substances in drainage manner - Google Patents
Medicine for expelling noxious substances in drainage manner Download PDFInfo
- Publication number
- CN105999219A CN105999219A CN201610564142.XA CN201610564142A CN105999219A CN 105999219 A CN105999219 A CN 105999219A CN 201610564142 A CN201610564142 A CN 201610564142A CN 105999219 A CN105999219 A CN 105999219A
- Authority
- CN
- China
- Prior art keywords
- medicine
- drain
- expelling
- noxious substances
- ibuprofen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 230000001473 noxious effect Effects 0.000 title abstract 5
- 239000000126 substance Substances 0.000 title abstract 5
- 229940079593 drug Drugs 0.000 title description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960001680 ibuprofen Drugs 0.000 claims abstract description 18
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 16
- 239000003053 toxin Substances 0.000 claims description 30
- 231100000765 toxin Toxicity 0.000 claims description 30
- 241000124079 Mylabris Species 0.000 claims description 21
- 229960003180 glutathione Drugs 0.000 claims description 15
- 235000003969 glutathione Nutrition 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 206010052428 Wound Diseases 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 206010037660 Pyrexia Diseases 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 5
- 230000001988 toxicity Effects 0.000 abstract description 5
- 231100000241 scar Toxicity 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 241000623906 Lytta vesicatoria Species 0.000 abstract 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000014674 injury Diseases 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229910052957 realgar Inorganic materials 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001819 hydrarthrosis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Insects & Arthropods (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for expelling noxious substances in a drainage manner, and belongs to the technical field of traditional Chinese medicine processing. The medicine for expelling the noxious substances in the drainage manner is prepared from lyttavesicatoria, reduced glutathione, ibuprofen and honey, and has the excellent functions of reducing toxicity of the lyttavesicatoria, facilitating expelling the noxious substances in the drainage manner, eliminating inflammation, abating fever, relieving pain and restoring wounds without leaving scars. The medicine can enable the skin to automatically drain to expel various noxious substances in body without cutting the skin by a needle, a knife or other tools, thereby curing diseases quickly.
Description
The application is for 2014 CN2014108039669(applyings date December 19 days, denomination of invention: for the medicine of drain toxin expelling) divisional application made.
Technical field
The invention belongs to the processing technique field of Chinese herbal medicine, particularly relate to a kind of medicine for drain toxin expelling.
Background technology
The Chinese medicine of motherland is of extensive knowledge and profound scholarship, method and medicine that the traditional Chinese medical science is cured the disease have a lot of ingenious practical invaluable experience, the Mylabris commonly used such as forefathers is equipped with Realgar, Mel for losing meat cited stream, discharging internal toxin, reach the purpose for the treatment of, but Mylabris, Realgar are all poisonous things, both gatherings add its toxicity.Of the present invention is to alleviate Mylabris toxicity, the most beneficially drain toxin expelling, tool anti-inflammation and sterilization, analgesia of bringing down a fever, the benign pharmaceutical of reparation wound preventing from scar.
Summary of the invention
For the medicine of drain toxin expelling, use Mylabris, reduced glutathion, ibuprofen, Mel to make, have and alleviate Mylabris toxicity, beneficially drain toxin expelling, have again anti-inflammation and sterilization, analgesia of bringing down a fever, the excellent effect of reparation wound preventing from scar.The medicine of the present invention, without cutting skin with other instrument such as pin or cutter, can allow skin automatic jet discharge internal various toxin, cure disease quickly.
The technical measures that the present invention takes:
For the medicine of drain toxin expelling, it is characterized in that: weigh raw material by weight: Mylabris 4-10 part, reduced glutathion 1.5-3 part, ibuprofen 0.5-2 part, the on-demand use of Mel.
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.(ibuprofen be granular should be ground into powder)
Compared with prior art, the method have the advantages that:
1, the medicine that the present invention uses is compared with prior art, it is possible to alleviates the toxicity of Mylabris, beneficially drain toxin expelling, has again anti-inflammation and sterilization, and the excellent effect of wound preventing from scar is repaired in analgesia of bringing down a fever.
2, antidote reduced glutathion is biological preparation, has good various metals toxin and the effect of Mylabris toxin in Mylabris body that release, and also has suppression melanin and generates the activity of enzyme, reduces the formation of dermal melanin.
3, medicine can drain toxin expelling treatment disease: heating inflammation purulence redness of various symptoms, arthromyodynia abscess pain, skin, hydrarthrosis pain, the wet hydrops of water, phlegm-damp assemble pain, blood stasis coalesce cold type of pain, gout swelling, traumatic injury wound congestive edema, ulcerative carbuncle toxic swelling etc..
4, this safety of medicine, novelty, practicality, simple, easy of use, determined curative effect.
Detailed description of the invention:
For the medicine of drain toxin expelling, it is characterized in that: weigh raw material by weight: Mylabris 4-10 part, reduced glutathion 1.5-3 part, ibuprofen 0.5-2 part, the on-demand use of Mel.
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment
1
For the medicine of drain toxin expelling, it is characterized in that: weigh raw material by weight: Mylabris 4 parts, reduced glutathion 1.5 parts, ibuprofen 0.5 part, the on-demand use of Mel.
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment
2
For the medicine of drain toxin expelling, it is characterized in that: weigh raw material by weight: Mylabris 10 parts, reduced glutathion 3 parts, ibuprofen 2 parts, the on-demand use of Mel.
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment
3
For the medicine of drain toxin expelling, it is characterized in that: weigh raw material by weight: Mylabris 5 parts, reduced glutathion 1.5 parts, ibuprofen 1 part, the on-demand use of Mel.
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Using method:By affected part alcohol disinfecting, provoke trace drug with toothpick and apply ointment or plaster affected part, about Semen phaseoli radiati size, a few place of strong opponent cloth-like multiple spot medicine as big in affected part area, apply trauma plaster at powder and fix, raise after 6-8 hour, i.e. see a blister at patch medicine, needle with sterile needle, can drain toxin expelling.After wound wound healing, as disease is not fully recovered, can drain toxin expelling again, take the circumstances into consideration with the use of the Chinese patent medicine dialling taking poison and growing muscle due simultaneously.
Note: avoid and eat Semen arachidis hypogaeae, Semen Glycines, beef, Cyprinus carpio, pan-fried, fried, the food of pungent stimulation.
Said medicine does not enters that eye is fine, anemia of pregnant woman's disabling
Wherein, the efficacy effect of each medicine, treatment disease is as follows:
Mylabris is pungent, warm, malicious greatly, returns liver, stomach, kidney channel.Counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation, cure mainly carbuncle, scrofula, stubborn dermatitis, amenorrhea, cancerous protuberance.Dead flesh can be lost, attack Fructus Myricae rubrae malignant boil, by blood reason pain." not Lu ": " main scabies, accumulation of blood, induced abortion." " property of medicine opinion ": " control scrofula, tonneau water channel.”
Reduced glutathion white crystals (general merchandise is pale yellow powder) is dissolved in water, there are removing free radical and antioxidative effect, there are releasing metal toxin and the toxic action of epoxide, melanin can be suppressed to generate the activity of enzyme, reduce melanic formation, improve skin oxidation resistance and make skin produce gloss.Also has liver-protective effect.
Ibuprofen has another name called Ibuprofen, ibuprofen, and this product is non-steroidal anti-inflammatory drugs, has analgesia and brings down a fever and antiinflammation.For rheumatism and rheumatoid arthritis, for pain, the pain of alleviation gouty arthritis.
Mel is sweet, put down, return spleen, stomach, lung, large intestine channel, invigorating middle warmer, cough-relieving, moisturizes, detoxifies, used herein as removing toxic substances and the viscous and effect of medicine.
Clinical practice:
Patient 24 people of traumatic injury wound congestive edema, 12 people are after 3 drain toxin expelling usings method, then the relative medicine in affected part application therapy traumatic injury wound, and 6 people's recoveries from illness, 4 people are clearly better, and 2 people are effective.12 people are after 4 drain toxin expellings, then take the medicine treating traumatic injury wound, and 8 people's recoveries from illness, 3 people are clearly better, and 1 people is invalid.
Rheumatism arthromyodynia, cold-damp arthromyodynia, patient 37 people of gouty arthritis, after 8-9 drain toxin expelling method, then apply ointment or plaster the medicine of corresponding treatment and edible medicine at affected part, and 12 people's recoveries from illness, 16 people are clearly better, and 6 people are effective, and 3 people are invalid.
Claims (1)
1., for the medicine of drain toxin expelling, it is characterized in that, weigh raw material by weight: Mylabris 5 parts, reduced glutathion 1.5 parts, ibuprofen 1 part, the on-demand use of Mel,
Mylabris is removed head, foot, wing and impurity, dries sterilization, be ground into powder, add reduced glutathion and ibuprofen mixing, add trace Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610564142.XA CN105999219A (en) | 2014-12-19 | 2014-12-19 | Medicine for expelling noxious substances in drainage manner |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610564142.XA CN105999219A (en) | 2014-12-19 | 2014-12-19 | Medicine for expelling noxious substances in drainage manner |
| CN201410803966.9A CN104474528B (en) | 2014-12-19 | 2014-12-19 | Medications for Drainage and Detoxification |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410803966.9A Division CN104474528B (en) | 2014-12-19 | 2014-12-19 | Medications for Drainage and Detoxification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105999219A true CN105999219A (en) | 2016-10-12 |
Family
ID=52749229
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610564142.XA Withdrawn CN105999219A (en) | 2014-12-19 | 2014-12-19 | Medicine for expelling noxious substances in drainage manner |
| CN201410803966.9A Active CN104474528B (en) | 2014-12-19 | 2014-12-19 | Medications for Drainage and Detoxification |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410803966.9A Active CN104474528B (en) | 2014-12-19 | 2014-12-19 | Medications for Drainage and Detoxification |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN105999219A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126070A (en) * | 2015-09-05 | 2015-12-09 | 佛山市顺德区宝铜金属科技有限公司 | Medicine for external treatment of scrofula and thyroid tumor |
| CN105126069A (en) * | 2015-09-05 | 2015-12-09 | 佛山市顺德区宝铜金属科技有限公司 | Medicine for external treatment of scrofula and gall |
| CN105169365A (en) * | 2015-09-05 | 2015-12-23 | 佛山市顺德区宝铜金属科技有限公司 | Medicine for external treatment of scrofula and gall |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1083720A (en) * | 1993-02-03 | 1994-03-16 | 金惠生 | " Lingdan " moxibustion plaster |
| CN1083720C (en) * | 1998-11-19 | 2002-05-01 | 潘建新 | Chinese patent drug for curing cirrhosis and splenceratosis disease |
-
2014
- 2014-12-19 CN CN201610564142.XA patent/CN105999219A/en not_active Withdrawn
- 2014-12-19 CN CN201410803966.9A patent/CN104474528B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104474528B (en) | 2016-09-07 |
| CN104474528A (en) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103961636B (en) | Orthopedic disease treatment external application traditional Chinese medicine composition, preparation method and application thereof | |
| CN104523969A (en) | Medicine for treating arthromyodynia due to kidney-yang deficiency | |
| CN101062217A (en) | Medicine combination for treating traumatic injury and the preparing method and the function thereof | |
| CN104524530A (en) | Traditional Chinese medicine composition and application of traditional Chinese medicine composition in preparation of medicine for treating arthralgia and myalgia | |
| CN105999219A (en) | Medicine for expelling noxious substances in drainage manner | |
| CN103638237B (en) | External traumatic medicine composition, external traumatic medicinal oil and preparation method thereof | |
| CN103432551B (en) | Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia | |
| CN109432269A (en) | A kind of Chinese medicine composition and preparation method, purposes | |
| CN104490991B (en) | For treating HPV papillomavirus Chinese medicine composition, preparation method and preparation | |
| CN103690583B (en) | A kind of medicated wine and its preparation method and application | |
| CN102038778A (en) | Chinese medicinal composition with effects of relaxing meridians, activating collaterals, expelling wind and removing dampness and preparation method thereof | |
| CN104873574A (en) | Ointment for relieving pain | |
| CN104306562A (en) | Ointment for treating blister type beriberi and preparing method thereof | |
| CN100556425C (en) | A kind of traditional Chinese medicinal ointment for stopping bleeding, relieving pain, promoting muscle regeneration and suppressing sores | |
| CN102697928B (en) | Preparation method for medicine composition for treating traumatic injury | |
| CN101244138B (en) | Externally used traditional Chinese medicine preparation for treating frostbite | |
| CN103611007A (en) | Ointment and preparation method thereof | |
| CN116036225B (en) | A naturally derived external pharmaceutical composition for treating arthritis | |
| CN102302636A (en) | Medicament for treating burn and preparation method thereof | |
| CN104257931A (en) | Orthopedic traumatic injury external application patch and preparation method thereof | |
| CN105816793A (en) | Traditional Chinese medicine for treating various hyperplasia and cyst diseases and preparation method thereof | |
| CN108261463A (en) | A kind of windproof Chinese medicine of folium artemisiae argyi controls cutaneous pruritus effervescent tablet | |
| CN104887702A (en) | Chinese medicinal composition for treating skin injury and ulceration and preparation method thereof | |
| CN106560205A (en) | Composite cream for treating blister type tinea pedis | |
| CN105687424A (en) | Ointment for treating traumatic injuries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161012 |
|
| WW01 | Invention patent application withdrawn after publication |